Dicural
difloxacin
Table of contents
Withdrawn
This medicine is now withdrawn from use in the European Union.
Overview
The marketing authorisation for Dicural has been withdrawn at the request of the marketing authorisation holder.
This EPAR was last updated on 29/10/2015
Authorisation details
| Product details | |
|---|---|
| Name |
Dicural
|
| Agency product number |
EMEA/V/C/000031
|
| Active substance |
difloxacin
|
| International non-proprietary name (INN) or common name |
difloxacin
|
| Species |
|
| Anatomical therapeutic chemical veterinary (ATCvet) codes |
QJ01MA94
|
| Publication details | |
|---|---|
| Marketing-authorisation holder |
Pfizer Limited
|
| Revision |
7
|
| Date of issue of marketing authorisation valid throughout the European Union |
16/01/1998
|
| Contact address |
Ramsgate Road
Sandwich Kent CT13 9NJ United Kingdom |
Product information
28/10/2015 Dicural - EMEA/V/C/000031 - IAIN/0021
Contents
- Annex I - Summary of product characteristics
- Annex IIA - Manufacturing-authorisation holder responsible for batch release
- Annex IIB - Conditions of the marketing authorisation
- Annex IIIA - Labelling
- Annex IIIB - Package leaflet
Please note that the size of the above document can exceed 50 pages.
You are therefore advised to be selective about which sections or pages you wish to print.
Pharmacotherapeutic group
Pharmacotherapeutic group
-
Antibacterials for systemic use
-
Antiinfectives for systemic use
Therapeutic indication
Therapeutic indication
Chickens:
for the treatment of chronic respiratory infections caused by sensitive strains of Escherichia coli and Mycoplasma gallisepticum.
Turkeys:
- For the treatment of chronic respiratory infections caused by sensitive strains of Escherichia coli and Mycoplasma gallisepticum.
- Also for the treatment of infections caused by Pasteurella multocida.
Dogs:
- For the treatment of acute uncomplicated urinary-tract infections caused by Escherichia coli or Staphylococcus spp. and superficial pyoderma caused by Staphylococcus intermedius.
Cattle:
- For the treatment of bovine respiratory disease (shipping fever, calf pneumonia) caused by single or mixed infections with Pasteurella haemolytica, Pasteurella multocida and / or Mycoplasma spp.